Visugromab in Cachexia International Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Visugromab in Cachexia International Trial — Stella

Recruiting

Back to Cancer-associated Cachexia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Mid Florida Hematology and Oncology Centers, Orange City, Florida

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

CatalYm GmbH

Enrollment target

~518 participants

Started

April 2026

Primary completion

December 2029

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov